Back to RU Rubric Capital Management LP
AMRX
Showing 8 of 14 quarters
Position history for RURubric Capital Management LP's holdings in Amneal Pharmaceuticals, Inc.
Yes. Rubric Capital Management holds 8,536,755 shares of AMRX (Amneal Pharmaceuticals), worth $171.9M, as of its Q3 2026 13F filing. It reduced the position by 1,631,905 shares (-16.0%) from Q2 2026. Rubric Capital Management has held AMRX since Q2 2023, across 14 quarterly 13F filings. AMRX is 1.6% of Rubric Capital Management's reported 13F portfolio.
Current Value
$171.9M
Current Shares
8.5M
Total Value Change
+$87M
Total Shares Change
-2.2M
Quarter-by-Quarter History